Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 1
1998 2
1999 6
2000 4
2001 2
2002 3
2003 2
2004 2
2005 5
2006 2
2007 3
2008 5
2009 7
2010 3
2011 9
2012 7
2013 9
2014 13
2015 12
2016 12
2017 10
2018 11
2019 8
2020 8
2021 7
2022 5
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
Atopic March: Collegium Internationale Allergologicum Update 2020.
Aw M, Penn J, Gauvreau GM, Lima H, Sehmi R. Aw M, et al. Among authors: gauvreau gm. Int Arch Allergy Immunol. 2020;181(1):1-10. doi: 10.1159/000502958. Epub 2019 Oct 8. Int Arch Allergy Immunol. 2020. PMID: 31593946 Free article. Review.
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR. Gauvreau GM, et al. N Engl J Med. 2014 May 29;370(22):2102-10. doi: 10.1056/NEJMoa1402895. Epub 2014 May 20. N Engl J Med. 2014. PMID: 24846652 Free article. Clinical Trial.
Allergen-induced airway responses.
Gauvreau GM, El-Gammal AI, O'Byrne PM. Gauvreau GM, et al. Eur Respir J. 2015 Sep;46(3):819-31. doi: 10.1183/13993003.00536-2015. Epub 2015 Jul 23. Eur Respir J. 2015. PMID: 26206871 Free article. Review.
Anti-alarmin approaches entering clinical trials.
Gauvreau GM, White L, Davis BE. Gauvreau GM, et al. Curr Opin Pulm Med. 2020 Jan;26(1):69-76. doi: 10.1097/MCP.0000000000000615. Curr Opin Pulm Med. 2020. PMID: 31408015 Review.
Inhaled allergen bronchoprovocation tests.
Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlén B, O'Byrne PM. Diamant Z, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2013 Nov;132(5):1045-1055.e6. doi: 10.1016/j.jaci.2013.08.023. Epub 2013 Oct 11. J Allergy Clin Immunol. 2013. PMID: 24119772 Review.
Antialarmins for treatment of asthma: future perspectives.
Al-Sajee D, Oliveria JP, Sehmi R, Gauvreau GM. Al-Sajee D, et al. Among authors: gauvreau gm. Curr Opin Pulm Med. 2018 Jan;24(1):32-41. doi: 10.1097/MCP.0000000000000443. Curr Opin Pulm Med. 2018. PMID: 29084017 Review.
Severe asthma: future treatments.
O'Byrne PM, Naji N, Gauvreau GM. O'Byrne PM, et al. Among authors: gauvreau gm. Clin Exp Allergy. 2012 May;42(5):706-11. doi: 10.1111/j.1365-2222.2012.03965.x. Clin Exp Allergy. 2012. PMID: 22515391 Review.
Novel targeted therapies for eosinophilic disorders.
Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, Simon HU, Wardlaw A, Weller PF, Klion AD. Wechsler ME, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2012 Sep;130(3):563-71. doi: 10.1016/j.jaci.2012.07.027. J Allergy Clin Immunol. 2012. PMID: 22935585 Free PMC article. Review.
Eculizumab for treatment of asthma.
Smith SG, Watson B, Clark G, Gauvreau GM. Smith SG, et al. Among authors: gauvreau gm. Expert Opin Biol Ther. 2012 Apr;12(4):529-37. doi: 10.1517/14712598.2012.668517. Expert Opin Biol Ther. 2012. PMID: 22413827 Review.
148 results